Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-45,450
Closed -$3.41M 31
2021
Q3
$3.41M Hold
45,450
0.81% 25
2021
Q2
$3.53M Sell
45,450
-2,182
-5% -$162K 0.74% 27
2021
Q1
$3.5M Hold
47,632
0.77% 26
2020
Q4
$3.72M Buy
+47,632
New +$3.64M 0.66% 31

Other funds holding MRK

Nan Fung Trinity's MRK Position: Q4 2021 in Review

Nan Fung Trinity sold out of Merck (MRK) in Q4 2021, closing a stake of 45,450 shares — an estimated $3.41M sold.

Nan Fung Trinity first reported a position in MRK in Q4 2020 and held it in 4 quarters. The position peaked at $3.72M in Q4 2020. 2,903 funds tracked by Wall St. Rank hold MRK as of Q4 2021.

  • Nan Fung Trinity reported no remaining Merck position as of Q4 2021 after selling out during the quarter.
  • Nan Fung Trinity sold 45,450 Merck shares in Q4 2021, an estimated $3.41M.
  • Nan Fung Trinity first reported a position in Merck in Q4 2020 and held it in 4 quarters.
  • Nan Fung Trinity's Merck position peaked at $3.72M in Q4 2020.
  • 2,903 funds tracked by Wall St. Rank held Merck as of Q4 2021.

Based on Nan Fung Trinity's 13F filing for Q4 2021, filed 21 Jan 2022.